Product Program year 2025 Source: CMS Open Payments

Cerebroflo Evd Catheter Set

Device Neuro Critical Care

PDI 00866614000108

Open in the dashboard

General payments

$9,258

12 payments

Research payments

$533,082

91 payments

Through program year 2025, $9,258 in general payments and $533,082 in research payments were reported against Cerebroflo Evd Catheter Set (Neuro Critical Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 Research $134,601 36
2024 Research $219,454 43
2023 Research $94,049 6
2022 Research $76,106 5
2021 General $9,258 12
2021 Research $8,873 1

Breakdown

Who paid General payments · program year 2021
  1. Integra LifeSciences Corporation $9,258 12 payments
Top recipients General payments · program year 2021
  1. Langley Porter Psychiatric Hospital Teaching hospital · CA $5,000 54% · 1 payment
  2. Adam De Havenon Vascular Neurology · New Haven, CT $4,000 43% · 1 payment
  3. Azadeh Farin Neurological Surgery · Long Beach, CA $141 2% · 4 payments
  4. Makell Murphy Physician Assistant, Surgical · Long Beach, CA $69 <1% · 3 payments
  5. Albert Lin Physician Assistant, Surgical · Orange, CA $16 <1% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Vascular Neurology Psychiatry & Neurology $4,000 94% · 1 practitioner
  2. Neurological Surgery $141 3% · 1 practitioner
  3. Physician Assistant, Surgical Physician Assistant $85 2% · 2 practitioners
  4. Physician Assistant $16 <1% · 1 practitioner
  5. Clinical Nurse Specialist, Neuroscience Clinical Nurse Specialist $16 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. California $5,242 57% · 5 recipients
  2. Connecticut $4,000 43% · 1 recipient
  3. Michigan $16 <1% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

12 general · 91 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record